Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.34ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
JN.1.34ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
JN.1.34ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-13317.5China
JN.1.34ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
JN.1.34ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-14207.5Hong Kong
JN.1.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.34SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
JN.1.34SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-27219.1China
JN.1.34SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
JN.1.34SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
JN.1.34SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
JN.1.34EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.34ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.34ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.34EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.34EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.34NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
JN.1.34NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.1.34NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JN.1.34NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
JN.1.34NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
JN.1.34NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
JN.1.34NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.34NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.34NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
JN.1.34NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
JN.1.34NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JN.1.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.34NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.34NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
JN.1.34NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.34NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.34NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
JN.1.34NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
JN.1.34NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
JN.1.34NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
JN.1.34NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.34NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.34NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.34ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-2242.74Japan
JN.1.34ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-26378.9Japan
JN.1.34ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-1981.59Japan
JN.1.34ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-21257.9Japan
JN.1.34ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-2648.21Japan
JN.1.34ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
JN.1.34SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used